The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
Abstract
NF-kappaB (nuclear factor-kappaB) is a collective name for inducible dimeric transcription factors composed of members of the Rel family of DNA-binding proteins that recognize a common sequence motif. NF-kappaB is found in essentially all cell types and is involved in activation of an exceptionally large number of genes in response to infections, inflammation, and other stressful situations requiring rapid reprogramming of gene expression. NF-kappaB is normally sequestered in the cytoplasm of nonstimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NF-kappaB is controlled by a family of inhibitory proteins, IkappaBs, which bind NF-kappaB and mask its nuclear localization signal, thereby preventing nuclear uptake. Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkappaB, which frees NF-kappaB to translocate to the nucleus where it regulates gene transcription. NF-kappaB activation represents a paradigm for controlling the function of a regulatory protein via ubiquitination-dependent proteolysis, as an integral part of a phosphorylationbased signaling cascade. Recently, considerable progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1. The multisubunit Ika…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of its ability to regulate the expression of inflammatory proteins, NFκB is believed to play a major role in the inflammatory process.”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
In the citing paper
“NFκB-induced gene expression requires that NFκB not only becomes activated, but it must also be phosphorylated and must physically translocate from cytoplasm to the nucleus (Karin and Ben-Neriah, 2000).”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The N-end rule: functions, mysteries, uses
Varshavsky, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12142 · Cited by 859
A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway
Belvin, M. P., & Anderson, K. V. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.393 · Cited by 836
A common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612
A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
Lee, S.-J., Dimtchev, A., Lavin, M. F., Dritschilo, A., & Jung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202088 · Cited by 136
Research works printed but not linked: 229
- 10.1016/0092-8674(86)90807-X · DOI
- Baldwin AS. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–81 · DOI
- Ghosh S, May MJ, Kopp EB. 1998. NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–60 · DOI
- 10.1016/S0065-230X(08)60257-2 · DOI
- 10.1146/annurev.cb.10.110194.002201 · DOI
- 10.1006/scbi.1997.0060 · DOI
- Whiteside ST, Israël A. 1997. I κ B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75–82 · DOI
- 1997, J. Cell Sci., 110, 369, 10.1242/jcs.110.3.369 · DOI
- 10.1128/MCB.16.5.2341 · DOI
- 10.1101/gad.9.22.2736 · DOI
- 10.1084/jem.188.6.1055 · DOI
- 10.1038/34356 · DOI
- 10.1038/nsb0198-67 · DOI
- 10.1038/373303a0 · DOI
- 10.1038/373311a0 · DOI
- 10.1016/S0092-8674(00)81699-2 · DOI
- 10.1016/S0092-8674(00)81698-0 · DOI
- 10.1016/S0065-2776(08)60742-7 · DOI
- 10.1056/NEJM199704103361506 · DOI
- 10.1146/annurev.biochem.67.1.227 · DOI · Paper page
- 10.1146/annurev.immunol.15.1.749 · DOI · Paper page
- 1995, Microbiol. Rev., 59, 481, 10.1128/mr.59.3.481-505.1995 · DOI
- 10.1006/meth.1998.0646 · DOI
- Baichwal VR, Baeuerle PA. 1997. Activate NF-κB or die? Curr. Biol. 7:R94–96 · DOI
- 10.1006/scbi.1997.0062 · DOI
- 1996, Oncogene, 13, 1367
- 10.1006/scbi.1997.0061 · DOI
- Grilli M, Memo M. 1999. NF-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57:1–7 · DOI
- 10.1073/pnas.95.14.8211 · DOI
- 10.1183/09031936.98.12010221 · DOI
- 10.1136/gut.43.6.856 · DOI
- 10.1128/MCB.15.5.2809 · DOI
- 10.1126/science.7878466 · DOI · Paper page
- 10.1128/MCB.15.3.1302 · DOI · Paper page
- 10.1128/MCB.16.4.1295 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07287.x · DOI
- 10.1128/MCB.15.10.5339 · DOI
- 10.1038/25159 · DOI
- 10.1016/S0092-8674(00)80752-7 · DOI
- 10.1101/gad.13.5.505 · DOI
- 10.1101/gad.9.13.1586 · DOI
- 10.1073/pnas.92.24.11259 · DOI
- 10.1074/jbc.271.1.376 · DOI
- 10.1073/pnas.92.23.10599 · DOI
- Lin Y-C, Brown K, Siebenlist U. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB: Signal-induced phosphorylation of IκB alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:3003–9 · DOI
- 10.1016/S0092-8674(00)80153-1 · DOI
- 10.1073/pnas.96.2.429 · DOI
- 10.1093/emboj/17.17.5170 · DOI
- 10.1073/pnas.95.22.13012 · DOI
- 10.1038/41493 · DOI · Paper page
- Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: cytokineactivated IκB kinases essential for NFκB activation. Science 278:860–66 · DOI
- 10.1016/S0092-8674(00)81064-8 · DOI
- 10.1016/S0092-8674(00)81842-5 · DOI
- 10.1016/S0092-8674(00)80406-7 · DOI
- 10.1016/S0092-8674(00)80344-X · DOI
- 10.1126/science.278.5339.866 · DOI
- 1995, Cell. Mol. Biol. Res., 41, 537
- 10.1038/26261 · DOI
- 10.1016/S0092-8674(00)81466-X · DOI
- 10.1128/MCB.19.2.1526 · DOI
- 10.1073/pnas.96.3.1042 · DOI
- 1990, J. Immunol., 145, 3080, 10.4049/jimmunol.145.9.3080 · DOI
- 10.1038/26254 · DOI
- 10.1046/j.1432-1327.1999.00028.x · DOI
- 10.1016/S1097-2765(00)80179-3 · DOI
- Zandi E, Chen Y, Karin M. 1998. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 281:1360–63 · DOI
- 10.1126/science.284.5412.321 · DOI
- 10.1084/jem.189.11.1839 · DOI
- 10.1016/S1074-7613(00)80042-4 · DOI
- 10.1074/jbc.274.22.15297 · DOI
- 10.1074/jbc.273.20.12041 · DOI
- 10.1074/jbc.273.46.30736 · DOI
- 10.1073/pnas.95.7.3792 · DOI
- 10.1126/science.284.5412.309 · DOI
- 10.1016/S0092-8674(00)81092-2 · DOI
- 10.1128/MCB.19.3.2180 · DOI
- 10.1128/MCB.18.10.5899 · DOI
- 10.1038/43474 · DOI · Paper page
- 10.1038/43466 · DOI · Paper page
- 10.1128/MCB.18.12.7336 · DOI
- 10.1073/pnas.95.16.9319 · DOI
- 10.1128/MCB.19.1.21 · DOI
- 10.1023/A:1021925629248 · DOI
- 10.1038/18465 · DOI
- 10.1074/jbc.274.15.10641 · DOI
- 10.1038/385540a0 · DOI
- Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factorκB and c-jun N-terminal kinase (JNK/ SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792–96 · DOI
- Baud V, Liu Z-G, Bennett B, Suzuki N, Xia Y, Karin M. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an N-terminal effector domain. Genes Dev. 13:1297– 308 · DOI
- 10.1126/science.284.5412.316 · DOI
- 10.1126/science.284.5412.313 · DOI
- 10.1038/8780 · DOI
- 10.1093/intimm/8.1.23 · DOI
- 10.1101/gad.12.21.3369 · DOI
- 10.1016/S1074-7613(00)80390-8 · DOI
- 10.1016/S1074-7613(00)80391-X · DOI
- 10.1073/pnas.95.5.2307 · DOI
- 10.1146/annurev.ge.29.120195.002103 · DOI
- 10.1101/gad.5.10.1892 · DOI
- 10.1016/0092-8674(91)90014-P · DOI
- 10.1038/ng0197-42 · DOI
- 10.1038/ng0197-36 · DOI
- 10.1038/376167a0 · DOI
- 10.1016/S1074-7613(00)80451-3 · DOI
- 10.1073/pnas.96.6.2994 · DOI
- Vandenabeele P, Declercg W, Beyaert R, Fiers W. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392–99 · DOI · Paper page
- 10.1038/sj.onc.1202568 · DOI
- 10.1016/S0898-6568(98)00018-7 · DOI
- 10.1073/pnas.90.13.6155 · DOI
- Auron PE. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221–37 · DOI
- 10.1016/S1074-7613(00)80535-X · DOI · Paper page
- 10.1074/jbc.270.23.13757 · DOI
- Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837–47 · DOI
- Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin1 receptor. Science 271:1128–31 · DOI
- 10.1126/science.278.5343.1612 · DOI
- 10.1038/383443a0 · DOI
- 10.1101/gad.12.18.2821 · DOI
- 10.1016/S1359-6101(98)00023-9 · DOI
- 10.1038/19110 · DOI
- 10.1126/science.7544915 · DOI
- Liu Z-G, Hu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87:565– 76 · DOI · Paper page
- Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2: distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 16:19935–42 · DOI
- 10.1074/jbc.271.25.14661 · DOI
- 10.1101/gad.13.8.1015 · DOI
- 10.1074/jbc.273.35.22681 · DOI
- 10.1074/jbc.272.51.32102 · DOI
- 10.1126/science.275.5296.90 · DOI
- 10.1016/S1097-2765(00)80283-X · DOI
- 10.1016/S0959-437X(96)80062-1 · DOI
- 10.1006/scbi.1997.0059 · DOI
- 10.1006/dbio.1996.0308 · DOI
- 10.1038/35154 · DOI · Paper page
- 10.1016/S0014-5793(99)00322-1 · DOI
- 10.1042/0264-6021:3390227 · DOI
- 10.1016/S0952-7915(99)80003-X · DOI
- 10.1126/science.284.5418.1313 · DOI
- 10.1038/32195 · DOI
- Dushay MS, Asling B, Hultmark D. 1996. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343–47 · DOI
- Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–80 · DOI
- 10.1146/annurev.genet.30.1.405 · DOI
- 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- 10.1016/S0968-0004(97)01122-5 · DOI
- 10.1096/fasebj.11.14.9409544 · DOI
- 10.1016/0092-8674(93)90384-3 · DOI
- 10.1093/emboj/16.21.6325 · DOI · Paper page
- 10.1038/373081a0 · DOI
- 10.1038/10039 · DOI
- Zachariae W, Nosmyth K. 1999. Whose end is destruction: cell cycle division and the anaphase promoting complex. Genes Dev. 13:2039–58 · DOI
- Yamano H, Tsurumi C, Gannon J, Hunt T. 1998. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor. EMBO J. 17:5670– 78 · DOI
- 10.1016/S1097-2765(00)80126-4 · DOI
- 10.1016/S1097-2765(00)80286-5 · DOI
- Peters JM. 1998. SCF and APC: the yin and yang of cell cycle regulated proteolysis. Curr. Opin. Cell. Biol. 10:759–68 · DOI
- Patton EE, Willems AR, Tyers M. 1998. Combinatorial control in ubiquitindependent proteolysis: Don't Skp the Fbox hypothesis. Trends Genet. 14:236– 43 · DOI
- 10.1101/gad.13.12.1614 · DOI
- 10.1016/S1097-2765(00)80482-7 · DOI
- 10.1126/science.284.5414.657 · DOI
- 10.1038/20459 · DOI · Paper page
- 10.1128/MCB.18.2.732 · DOI
- 10.1126/science.284.5414.662 · DOI
- 10.1128/MCB.16.3.1058 · DOI
- 10.1093/emboj/16.21.6486 · DOI
- 10.1101/gad.7.7a.1266 · DOI
- 10.1002/j.1460-2075.1993.tb06157.x · DOI
- 10.1093/emboj/16.13.3797 · DOI
- 10.1126/science.275.5307.1790 · DOI
- 10.1126/science.275.5307.1787 · DOI
- 1998, Cancer Res., 58, 1344
- 10.1002/(SICI)1098-2264(199805)22:1<37::AID-GCC5>3.3.CO;2-P · DOI
- 1998, Cancer Res., 58, 2524
- 1998, Cancer Res., 58, 896
- 1998, Cancer Res., 58, 2520
- 1998, Cancer Res., 58, 1130
- 10.1073/pnas.95.15.8847 · DOI
- Spevak W, Keiper BD, Stratowa C, Castanon MJ. 1993. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats. Mol. Cell. Biol. 13:4953–66. Erratum. 1993. 13(11):7199 · DOI
- 10.1016/S1097-2765(00)80056-8 · DOI
- 10.1006/bbrc.1999.0289 · DOI
- 10.1073/pnas.96.7.3859 · DOI
- 10.1074/jbc.274.12.7941 · DOI
- 10.1101/gad.13.3.284 · DOI
- 10.1101/gad.13.21.2751 · DOI
- 10.1038/sj.onc.1202760 · DOI
- 10.1016/S0092-8674(00)81376-8 · DOI
- 1996, Nature, 379, 847
- 10.1038/360597a0 · DOI
- 10.1006/geno.1999.5792 · DOI
- 10.1016/S0960-9822(99)80091-8 · DOI
- 10.1093/emboj/18.9.2401 · DOI
- 10.1038/sj.onc.1202653 · DOI
- 10.1073/pnas.96.11.6273 · DOI
- 10.1016/S0925-4773(98)00134-8 · DOI
- 10.1016/S0304-419X(97)00008-5 · DOI
- 10.1016/S0165-4608(97)00479-2 · DOI
- 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.3.CO;2-R · DOI
- 10.1038/sj.onc.1202073 · DOI
- 10.1126/science.274.5288.782 · DOI · Paper page
- Wang C-Y, Mayo MW, Baldwin AS Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–87 · DOI
- 10.1016/S0092-8674(00)81409-9 · DOI
- 10.1038/354395a0 · DOI
- 10.1016/S0092-8674(94)90482-0 · DOI
- Orian A, Whiteside S, Israël A, Stancovski I, Schwartz AL, Ciechanover A. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105: reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270:21707– 14 · DOI
- 10.1074/jbc.273.15.8820 · DOI
200 of 229 shown
Cited by
Sorted by citations
Items 201–300 of 1,071
Li, C., Li, L., Chen, K., Wang, Y., Yang, F., & Wang, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6505373 · Cited by 39
Insuan, O., Janchai, P., Thongchuai, B., Chaiwongsa, R., Khamchun, S., Saoin, S., Insuan, W., Pothacharoen, P., Apiwatanapiwat, W., Boondaeng, A., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43010008 · Cited by 58
Zhang, X.-L., Lai, W., Ying, X., Xu, L., Chu, K., Brown, J., Chen, L., & Hong, G. (2019) · Inflammation · doi:10.1007/s10753-019-01045-7 · Cited by 58
Exercise and Glycemic Control: Focus on Redox Homeostasis and Redox-Sensitive Protein Signaling
Parker, L., Shaw, C. S., Stepto, N. K., & Levinger, I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00087 · Cited by 55
“Stress-activated protein kinase pathways are activated through numerous stimuli involving hormones, growth factors, cytokines, agents acting through G protein-coupled receptors, transforming growth factors, pathogens and danger-associated molecular patterns, and physical and chemical stresses (153, 155, 156).”
Fan, J.-Y., Fan, Y., Wang, X.-L., Xie, H., Gao, H.-J., Zhang, Y., Liu, M., & Tang, H. (2017) · FEBS Letters · doi:10.1002/1873-3468.12502 · Cited by 54
Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K., Kelley, C., Colonna, M., Schreiber, R. D., & Muglia, L. J. (2010) · Blood · doi:10.1182/blood-2009-06-224782 · Cited by 53
Pérez, R., Burgos, V., Marín, V., Camins, A., Olloquequi, J., González‐Chavarría, I., Ulrich, H., Wyneken, Ú., Luarte, A., Ortíz, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12081500 · Cited by 58
“In most cell types, NF-κB dimers are predominantly cytoplasmic because they are in constant interaction with NF-κB inhibitors (IkBα, IkBβ, IkBε and Bcl-3) remaining transcriptionally inactive [92].”
BackgroundPopichak, K. A., Hammond, S. L., Moreno, J. A., Afzali, M. F., Backos, D. S., Slayden, R. D., Safe, S., & Tjalkens, R. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112631 · Cited by 53
“…and extracellular stress signals through the IkBa kinase complex, causing translocation of the p50/p65 active transcription factor to the nucleus (Karin and Ben-Neriah, 2000); however, is not a tractable drug target given that knockoutmice for this pathway This work was supported by the National…”
BackgroundSeifar, F., Khalili, M., Khaledyan, H., Moghadam, S. A., Izadi, A., Azimi, A., & Shakouri, S. K. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1386755 · Cited by 67
The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases
Chou, C., Chang, Y., Kořínek, M., Chen, Y., Yang, Y.-T., Leu, S., Lin, I., Tang, C.-J., & Chiu, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030483 · Cited by 52
Besednova, N. N., Andryukov, B. G., Zaporozhets, T. S., Kuznetsova, T. A., Kryzhanovsky, S. P., Ermakova, S. P., Galkina, I. V., & Shchelkanov, M. Y. (2022) · Marine Drugs · doi:10.3390/md20040243 · Cited by 67
“NF-kB activity is regulated by different mechanisms depending on IkB accumulation and degradation, NF-kB phosphorylation, IKK hyperphosphorylation, and processing of NF-kB precursors [115].”
BackgroundThe Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 62
Buhrmann, C., Popper, B., Aggarwal, B. B., & Shakibaei, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186993 · Cited by 55
The central inflammatory regulator IκBζ: induction, regulation and physiological functions
Feng, Y., Chen, Z., Xu, Y., Han, Y., Jia, X., Wang, Z., Zhang, N., & Lv, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188253 · Cited by 58
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
Wu, X., Sun, L., & Xu, F. (2023) · Pharmaceuticals · doi:10.3390/ph16060783 · Cited by 51
“NF-κB could be stimulated by plenty of extracellular factors, which exhibit two different signal transduction cascades comprising the canonical and the non-canonical pathways [30,31].”
BackgroundZhang, Y., Feng, W., Xuan, P., Zhu, L., Wang, Z., Shen, H. M., Chen, C., Xiao, L., Li, S., Zhao, Y., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00834-3 · Cited by 61
Pellegrino, N., Güven, A., Gray, K., Shah, P., Kasture, G., Nastke, M.-D., Thakurta, A., Gesta, S., Vishnudas, V. K., Narain, N. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073480 · Cited by 58
“One of the major pathways regulated is the NF-κB signaling pathway.”
BackgroundInfluentialLiu, S.-W., Yu, J.-C., Fu, M., Wang, X., & Chang, X.-D. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110239 · Cited by 51
Bakheet, S., Alrwashied, B. S., Ansari, M. A., Nadeem, A., Attia, S., Alanazi, M., Aldossari, A. A., Assiri, M. A., Mahmood, H. M., Al-Mazroua, H., et al. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.06.014 · Cited by 51
Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway.
Wang, K.-S., Lv, Y., Wang, Z., Ma, J., Mi, C., Li, X., Xu, G., Piao, L.-X., Zheng, S.-Z., & Jin, X.-J. (2017) · Oncology Report · doi:10.3892/or.2017.5581 · Cited by 51
“Upon appropriate stimulation for example by TNF-α, IκB is phosphorylated by IκB kinases (IKKs), polyubiquitinated by a ubiquitin ligase complex, and degraded by the 26S proteasome (4,5).”
BackgroundEndogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Villatoro, A., Cuminetti, V., Bernal, A., Torroja, C., Cossío, I., Benguría, A., Ferré, M., Konieczny, J., Vázquez, E., Rubio, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35700-9 · Cited by 55
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD
Harari-Steinfeld, R., Gefen, M., Simerzin, A., Zorde‐Khvalevsky, E., Rivkin, M., Ella, E., Friehmann, T., Gerlic, M., Zucman‐Rossi, J., Caruso, S., et al. (2021) · Cancers · doi:10.3390/cancers13030411 · Cited by 50
“These results strongly suggest that miR-675 enhances liver inflammation via increased activation of NF-κB.”
BackgroundInfluentialWang, S., Ni, L., Fu, X., Duan, D., Xu, J., & Gao, X. (2020) · Marine Drugs · doi:10.3390/md18120593 · Cited by 52
Yang, R., Liu, S., Zhou, J., Bu, S.-H., & Zhang, J. (2017) · Immunopharmacology and immunotoxicology · doi:10.1080/08923973.2017.1344989 · Cited by 50
“ANDRO reduced the mRNA levels of TNF-a, IL-1b, COX-2, and iNOS in ab (1-42)-stimulated microglial cells”
BackgroundInhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo
Asare, Y., Ommer-Bläsius, M., Azombo, F. A., Alampour‐Rajabi, S., Sternkopf, M., Sanati, M., Gijbels, M. J., Schmitz, C., Sinitski, D., Tilstam, P. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618411114 · Cited by 56
Li, J.-B., Ma, J., Wang, K.-S., Mi, C., Wang, Z., Piao, L.-X., Xu, G., Li, X., Lee, J., & Jin, X.-J. (2016) · Oncology Report · doi:10.3892/or.2016.5108 · Cited by 50
Nuclear factor kappa B expression in non-small cell lung cancer
Zhang, L., Ludden, C. M., Cullen, A. J., Tew, K. D., de Barros, A. L. B., & Townsend, D. M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115459 · Cited by 50
“Instead, the C-terminal domains of p50 and p52 contain 6– 7 ankyrin repeats responsible for sequestration in the cytosol, a characteristic particular to NF-kB inhibitory proteins (IkB) [19].”
BackgroundMurphy, C., Lawther, A. J., Webster, M., Asai, M., Kondo, Y., Matsumoto, M., Walker, A., & Weickert, C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01890-6 · Cited by 49
Molecular mechanisms of action of naringenin in chronic airway diseases.
Chin, L.-H., Hon, C.-M., Chellappan, D., Chellian, J., Madheswaran, T., Zeeshan, F., Awasthi, R., Aljabali, A. A. A., Tambuwala, M., Dureja, H., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173139 · Cited by 49
Chen, Y., Fang, R., Yue, C., Chang, G., Li, P., Guo, Q., Wang, J., Zhou, A., Zhang, S., Fuller, G. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1229 · Cited by 69
“It is known that β-TrCP interacts with the DS(PO4)GXXS(PO4) degron of substrates (35).”
BackgroundCui, L., Wang, H., Lin, J., Wang, Y., Dong, J., Li, J., & Li, J. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103568 · Cited by 60
Targeting IκappaB kinases for cancer therapy
Awasthee, N., Rai, V., Chava, S. P., Nallasamy, P., Kunnumakkara, A. B., Bishayee, A., Chauhan, S. C., Challagundla, K. B., & Gupta, S. C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.007 · Cited by 53
“IκBα phosphorylation triggers the polyubiquitination (by E2- and E3-ligases) and subsequent degradation (by 26S proteasome) of IκBα [19].”
BackgroundChelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells
Zhang, Z. H., Mi, C., Wang, K.-S., Wang, Z., Li, M. Y., Zuo, H.-X., Xu, G., Li, X., Piao, L.-X., Ma, J., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.5948 · Cited by 49
“All members of the NF‐κB family harbor an N‐terminal Rel homology domain that is responsible for DNA binding, dimerization, and association with inhibitory proteins known as IκBs (Ghosh, May, Chelidonine; cIAP‐1, cellular enase‐2; FLIP, cellular FLICE a; IL‐8, interleukin 8; iNOS, yte chemotactic protein 1; lear facto…”
BackgroundNKILA inhibits NF-κB signaling and suppresses tumor metastasis
Ke, S., Li, R.-C., Meng, F.-K., & Fang, M.-H. (2018) · Aging · doi:10.18632/aging.101359 · Cited by 49
Zhang, H., Qi, Y., Yuan, Y., Cai, L., Xu, H., Zhang, L., Su, B., & Nie, H. (2017) · Scientific Reports · doi:10.1038/srep41887 · Cited by 48
Pakjoo, M., Ahmadi, S. E., Zahedi, M., Jaafari, N., Khademi, R., Amini, A., & Safa, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01433-5 · Cited by 54
“Phosphorylation of IκB proteins by the IKK complex (IKKα, IKKβ, and IKKγ) activates NF-κB [24, 70].”
BackgroundShi, J., Liu, Z., Li, M., Guo, J. Z., Chen, L., Ding, L., Ding, X., Zhou, T., & Zhang, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111669 · Cited by 48
Wang, Z., Yang, Y., Cui, Y.-C., Wang, C., Lai, Z., Li, Y.-S., Zhang, W., Mustonen, H., Puolakkainen, P., Ye, Y.-J., et al. (2020) · Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · doi:10.21147/j.issn.1000-9604.2020.01.09 · Cited by 48
Figueiredo, P. S., Inada, A. C., Fernandes, M. R., Arakaki, D. G., Freitas, K. D. C., Guimarães, R. D. C. A., do Nascimento, V. A., & Hiane, P. A. (2018) · Molecules · doi:10.3390/molecules23040877 · Cited by 48
Shrestha, S., Zhu, J., Wang, Q., Du, X., Liu, F., Jiang, J., Song, J., Xing, J., Sun, D., Hou, Q., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4097 · Cited by 52
“Phosphorylated I κ B proteins subsequently undergo proteasome-mediated degradation, thereby liberating free NF-κ B p65/p50 dimers to translocate to the nucleus that can then modulate gene transcription (41).”
Zheng, G., Jiang, C., Li, Y., Yang, D., Ma, Y., Zhang, B., Li, X., Zhang, P., Hu, X., Zhao, X., et al. (2019) · Protein & Cell · doi:10.1007/s13238-018-0563-2 · Cited by 48
Shi, P., Xu, J., & Cui, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210337 · Cited by 52
Ren, D.-Y., Wang, P., Liu, C.-L., Wang, J., Liu, X.-Q., Liu, J.-S., & Min, W.-H. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.024 · Cited by 47
Yuan, M., Chang, L., Gao, P., Li, J., Xin-yuan, L., Hua, M., Li, X., Liu, X., & Lan, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133794 · Cited by 50
D’Aloia, A., Molteni, L., Gullo, F., Bresciani, E., Artusa, V., Rizzi, L., Ceriani, M., Meanti, R., Lecchi, M., Coco, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063054 · Cited by 48
“The “canonical” pathway is triggered by microbial products and proinflammatory cytokines such as TNF-α and IL-1, usually leading to activation of RelA- or cRel-containing complexes [22].”
BackgroundSun, X., Luo, S., Jiang, C., Tang, Y., Cao, Z., Jia, H., Xu, Q., Zhao, C., Loor, J. J., & Xu, C. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-18189 · Cited by 47
“A variety of extracellular stimuli lead to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IκBα, which frees NF-κB to translocate to the nucleus, where it regulates transcription of tumor necrosis factor α (TNFA), interleukin-6 (IL6), and interleukin-1B (IL1B; Karin and Ben-Neriah,…”
BackgroundYang, M., Wang, Y., Patel, G., Xue, Q., Njateng, G. S. S., Cai, S., Cheng, G., & Kai, G. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113105 · Cited by 56
Moon, H., Cho, K., Shin, S., Kim, D. Y., Han, K., & Ro, S. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030581 · Cited by 56
“The most potent activators of NF-kB include inflammatory cytokines such as TNF-α or IL-1, as well as Toll-like receptors (TLRs) [68,69], which can also trigger cell proliferative signals through NF-Kb [70,71].”
BackgroundHu, Z.-L., Song, B., Xu, L., Zhong, Y.-L., Peng, F., Ji, X.-Y., Zhu, F., Yang, C., Zhou, J.-Y., Su, Y.-Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.047 · Cited by 46
“Phosphorylated IkB is degraded via a proteasome-mediated pathway, and NF-kB dimers are then released and translocate to the nucleus to activate gene transcription [8].”
BackgroundNADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation
Szántó, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052702 · Cited by 52
Fei, M., Li, Z., Cao, Y.-W., Jiang, C., Lin, H.-D., & Chen, Z.-X. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00606-5 · Cited by 45
“In the IKK complex, the catalytic subunit IKKβ has an important role in the phosphorylation of the IκB protein [10].”
BackgroundWu, X., Deng, M., Gao, Z., Dang, Y., Li, Y., & Li, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106559 · Cited by 52
Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa, C., Senba, M., & Mori, N. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172953 · Cited by 45
Altonsy, M. O., Kurwa, H. A., Lauzon, G. J., Amrein, M., Gerber, A. N., Almishri, W., & Mydlarski, P. R. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.284 · Cited by 42
“This enhances the transcription of target genes, including those encoding numerous inflammatory effector molecules.(41,42) Results presented above show the activation by infection with C.”
BackgroundSong, H.-M., Li, D.-F., Wu, T.-Q., Xie, D., Hua, K., Hu, J., Deng, X.-C., Ji, C., Deng, Y.-J., & Fang, L. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.11.168 · Cited by 45
“The NF-B signaling pathway has key roles in inflammation, immune response, oncogenesis and protection against apoptosis (10, 11).”
BackgroundBST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer
Liu, W., Cao, Y., Guan, Y., & Zheng, C.-Q. (2018) · Biotechnology Letters · doi:10.1007/s10529-018-2562-z · Cited by 45
PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development
Yu, M., Chen, Y., Zeng, H., Zheng, Y., Fu, G., Zhu, W., Broeckel, U., Aggarwal, P., Turner, A., Neale, G. A. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01388-5 · Cited by 55
The NF-κB signaling network in the life of T cells
Daniëls, M. A., & Teixeiro, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1559494 · Cited by 50
Yami, H. A., Tahmoorespur, M., Javadmanesh, A., Tazarghi, A., & Sekhavati, M. (2023) · Immunity, Inflammation and Disease · doi:10.1002/iid3.972 · Cited by 44
“Pro‐inflammatory stimuli, such as LPS, and pro‐inflammatory cytokines, such as TNF‐α, IL‐6, and IL‐1β, cause phosphorylation and ubiquitination of IκB, which consequently leads to its proteasomal degradation.(16) IκB kinase (IKK) complex with three subunits, including IKKα, IKKβ, and IKK/NF‐κB essential modulator (NEM…”
BackgroundFang, C., Xu, H., Yuan, L., Zhu, Z., Wang, X., Liu, Y., Zhang, A., Shao, A., & Lou, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1949718 · Cited by 46
The immunoproteasome: An old player with a novel and emerging role in alloimmunity
Eskandari, S., Seelen, M., Lin, G., & Azzi, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14435 · Cited by 44
Bui, T. T., Chun, H.-P., Chang, H.-S., Shin, H., & Chai, O.-H. (2017) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2017.04.133 · Cited by 44
MicroRNA-377: A therapeutic and diagnostic tumor marker
Akhlaghipour, I., Taghehchian, N., Zangouei, A. S., Maharati, A., Mahmoudian, R. A., Saburi, E., & Moghbeli, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.236 · Cited by 40
A conserved long noncoding RNA, GAPLINC, modulates the immune response during endotoxic shock
Vollmers, A., Covarrubias, S., Kuang, D., Shulkin, A., Iwuagwu, J., Katzman, S., Song, R., Viswanathan, K., Vollmers, C., Wakeland, E., et al. (2021) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2016648118 · Cited by 43
“Upon activation, I-κ B-α is degraded, allowing p65:p50 to translocate into the nucleus and activate target genes (20).”
Sun, X., Wang, Z., Shao, C., Yu, J., Liu, H., Chen, H., Li, L., Wang, X., Ren, Y., Huang, X., et al. (2021) · Veterinary Research · doi:10.1186/s13567-021-00896-z · Cited by 43
“Transcription factor Nuclear factor-κB (NF-κB) is a redox-sensitive transcription factor and modulates ILs production [46].”
BackgroundLIGHT aggravates sepsis‐associated acute kidney injury via TLR4‐MyD88‐NF‐κB pathway
Zhong, Y., Wu, S., Yang, Y., Li, G.-Q., Meng, L., Zheng, Q.-Y., Li, Y., Xu, G.-L., Zhang, K.-Q., & Peng, K.-F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15815 · Cited by 43
Effects of Vaspin on Insulin Resistance in Rats and Underlying Mechanisms
Liu, S., Duan, R., Wu, Y., Du, F., Zhang, J., Li, X., Guo, S., Wang, M., Zhang, Q., Li, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31923-3 · Cited by 46
Ranjit, S., Sinha, N., Kodidela, S., & Kumar, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-28500-z · Cited by 44
Effects of vaspin on pancreatic β cell secretion via PI3K/Akt and NF-κB signaling pathways
Liu, S., Li, X., Wu, Y., Duan, R., Zhang, J., Du, F., Zhang, Q., Li, Y., & Li, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189722 · Cited by 50
Nagao, M., Tanabe, N., Manaka, S., Naito, M., Sekino, J., Takayama, T., Kawato, T., Torigoe, G., Kato, S., Tsukune, N., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25777 · Cited by 43
“NF-κB p50 and p65 are existed as typical hererodimer (Karin & Ben-Neriah, 2000).”
BackgroundAnti-inflammatory Effects of Canthin-6-one Alkaloids from Ailanthus altissima
Cho, S.-K., Jeong, M., Jang, D., & Choi, J.-H. (2017) · Planta Medica · doi:10.1055/s-0043-123349 · Cited by 43
“It plays a critical role in inflammatory processes by regulating the expression of pro-inflammatory genes [23].”
BackgroundJiang, C.-Y., Zhu, Y., Zhou, Z.-C., Gumin, J., Bengtsson, L., Wu, W.-S., Zhou, S.-Y., Lang, F.-F., & Lin, X. (2017) · Oncogene · doi:10.1038/onc.2016.430 · Cited by 43
RSK2 and its binding partners in cell proliferation, transformation and cancer development
Cho, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0880-z · Cited by 46
The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease
Reddy, A. T., Lakshmi, S. P., Dornadula, S., Pinni, S., Rampa, D. R., & Reddy, R. C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300730 · Cited by 42
Monitoring the Levels of Cellular NF-κB Activation States
Meier‐Soelch, J., Mayr‐Buro, C., Juli, J. U., Leib, L., Linne, U., Dreute, J., Papantonis, A., Schmitz, M. L., & Kracht, M. (2021) · Cancers · doi:10.3390/cancers13215351 · Cited by 53
“Downstream of receptors, the various cytosolic activation pathways have in common that they involve the inducible formation of protein/protein interactions, which are controlled by highly regulated posttranslational modifications, primarily phosphorylation and ubiquitination [5,6].”
BackgroundXiong, F., Mao, R., Zhang, L., Zhao, R., Tan, K., Liu, C., Xu, J., Du, G., & Zhang, T. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04253-y · Cited by 51
Shi, J., Wang, J., Zhang, J., Li, X., Tian, X., Wang, W., Wang, P., & Li, M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6691 · Cited by 42
Exploring Dysregulated Signaling Pathways in Cancer
Nisar, S., Hashem, S., Macha, M. A., Yadav, S. K., Muralitharan, S., Therachiyil, L., Sageena, G., Al‐Naemi, H. A., Haris, M., & Bhat, A. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115095937 · Cited by 60
Shin, J., Im, H., & Lee, K. (2018) · Inflammation · doi:10.1007/s10753-018-0898-0 · Cited by 47
Thummuri, D., Guntuku, L., Challa, V. S., Ramavat, R. N., & Naidu, V. G. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26575 · Cited by 45
“Upon cytokine stimulation, IKKmediates the proteosomal degradation of IκBα by phosphorylation of IκBα at ser32 and ser36 and liberates NF-κB leading to its nuclear translocation (Karin & Ben-Neriah, 2000; Siebenlist, Franzoso, & Brown, 1994).”
BackgroundNF-κB Members Left Home: NF-κB-Independent Roles in Cancer
Colomer, C., Marruecos, L., Vert, A., Bigas, A., & Espinosa, L. (2017) · Biomedicines · doi:10.3390/biomedicines5020026 · Cited by 52
ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis
Ben-Shoshan, S. O., Kagan, P., Sultan, M., Barabash, Z., Dor, C., Jacob-Hirsch, J., Harmelin, A., Pappo, O., Marcu-Malina, V., Ben-Ari, Z., et al. (2017) · RNA Biology · doi:10.1080/15476286.2016.1203501 · Cited by 42
“Importantly, the latter kinase is a major component of the IKK complex that initiates the signaling cascade resulting in IkB degradation and enhanced NFkB p65 transcriptional activity.(29,34) Moreover, we could partly prevent IL6 overproduction in ADAR1 KD cells, by expressing editase deficient p110 and p150 ADAR1 iso…”
BackgroundAzimi, A., Ghaffari, S. M., Riazi, G. H., Arab, S. S., Tavakol, M. M., & Pooyan, S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.06.058 · Cited by 46
Fuertes‐Agudo, M., Luque-Tévar, M., Cucarella, C., Martín‐Sanz, P., & Casado, M. (2023) · Antioxidants · doi:10.3390/antiox12081491 · Cited by 48
“The canonical pathway is triggered by Toll-like receptors (TLRs) and pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin (IL)-1, leading to the expression of nuclear factor NF-κB p65 subunit (RELA gene), which regulates the expression of pro-inflammatory and cell survival genes [58].”
Yu, D., Cai, W., Shen, T., Wu, Y., Ren, C., Li, T., Hu, C., Zhu, M., & Yu, J. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09791-z · Cited by 47
“The p65 subunit of NF-κB released from IκBα is subsequently phosphorylated by IKKβ or other kinases and moves into the nucleus (Karin and Ben-Neriah 2000).”
BackgroundIhara, F., Fereig, R. M., Himori, Y., Kameyama, K., Umeda, K., Tanaka, S., Ikeda, R., Yamamoto, M., & Nishikawa, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01709 · Cited by 47
“Upon exposure to various infectious and inflammatory stimuli, the inhibitor proteins are phosphorylated, resulting in their ubiquitination and degradation, allowing the nuclear translocation of NFκB dimers to regulate gene expression (10).”
BackgroundShen, X.-F., Zhao, W., Zhang, Y., & Liang, B. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s220306 · Cited by 41
Annonaceae: Breaking the Wall of Inflammation
Attiq, A., Jalil, J., & Husain, K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00752 · Cited by 48
“Upon receiving the stimulus, 26S proteosome seeks the help of IκB kinases for the phosphorylation and polyubiquition of IκB (Karin and Ben-Neriah, 2000; Broide et al., 2005).”
BackgroundNovel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
Li, B., Cai, S.-S., Yang, Y.-A., Chen, S.-C., Chen, R., Shi, J.-B., Liu, X.-H., & Tang, W.-J. (2017) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2017.08.002 · Cited by 40
“NFκB activation is controlled by phosphorylation and degradation of I κB-α, a cognate regulatory subunit of NFκB [40].”
BackgroundWang, C., Yan, M.-Y., Jiang, H., Wang, Q., Guan, X., Chen, J., & Wang, C. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.09.010 · Cited by 40
Krajka‐Kuźniak, V., Belka, M., & Papierska, K. (2024) · Cancers · doi:10.3390/cancers16061092 · Cited by 43
“The phosphorylation of I κ B α triggers its ubiquitination and subsequent degradation, releasing NF-κ B dimers [68].”
Ha, S., Luo, G., & Xiang, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01487 · Cited by 48
The Multifaceted Roles of USP15 in Signal Transduction
Das, T., Song, E. J., & Kim, E. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094728 · Cited by 44
“Thus, USP15 inhibits NF-kB signaling and its downstream target genes by deubiquitination and stabilization of IkB in mammalian cells [33], as illustrated in Figure 2 (left).”
BackgroundInfluentialDual Role of the PTPN13 Tyrosine Phosphatase in Cancer
Mcheik, S., Aptecar, L., Coopman, P. J., D’Hondt, V., & Freiss, G. (2020) · Biomolecules · doi:10.3390/biom10121659 · Cited by 43
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells
Lork, M., Staal, J., & Beyaert, R. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.11.001 · Cited by 42
Harikrishnan, H., Jantan, I., Haque, M., & Kumolosasi, E. (2018) · Phytotherapy Research · doi:10.1002/ptr.6190 · Cited by 39
Shao, D., Lian, Z., Di, Y., Zhang, L., Rajoka, M. S. R., Zhang, Y., Kong, J., Jiang, C., & Shi, J. (2018) · npj Science of Food · doi:10.1038/s41538-018-0022-8 · Cited by 49
Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy
He, W., Li, Z., Gu, H.-Y., Pan, Q.-L., & Lin, F.-X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03814-w · Cited by 39
“In the IKK complex, the catalytic subunit IKKβ plays an important role in the phosphorylation of IκB protein [154]. miR‑182 inhibits the release of inflamma‑ tory factors, Bax, and caspase 3 by inactivating the IKKβ/ NF‑κB pathway, thereby inhibiting inflammatory response and apoptosis, ultimately…”
Andrés, C. M. C., de la Lastra, J. M. P., Andrés, C., Plou, F. J., & Pérez‐Lebeña, E. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23455 · Cited by 44
Li, M.-F., Wang, H., Lu, Y., & Cai, J. (2023) · Immunity, Inflammation and Disease · doi:10.1002/iid3.820 · Cited by 38
“NF‐κB signaling has been recognized as a typical proinflammatory signaling pathway, based on its effects on the expressions of proinflammatory genes, possibly through the activation of IL‐1 and tumor necrosis factor‐α (TNF‐α).(22,23) Also, the overexpression of receptors for advanced glycation end‐products perpetuates…”
Background
Metadata
- Authors
- Karin, M., & Ben-Neriah, Y.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction University of California, San Diego, La Jolla, California, 92093-0636;
- ORCID
- Karin, Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2000-04
- Volume
- 18
- Issue
- 1
- Pages
- 621-663
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2147921405
- Cited by
- 4,766
- References
- 243
- Citations by year
- 2026: 78 · 2025: 109 · 2024: 86 · 2023: 101 · 2022: 114 · 2021: 112 · 2020: 129 · 2019: 114 · 2018: 129 · 2017: 153 · 2016: 156 · 2015: 135 · 2014: 186 · 2013: 201 · 2012: 194
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA76188, R01CA076188)
- National Institute of Allergy and Infectious Diseases (R01AI043477, R01 AI43477)
- National Institute of Environmental Health Sciences (R37ES004151, R37 ES04151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, IκB phosphorylation, ubiquitination, IκB kinase, IKKα, IKKβ, E3 ubiquitin ligase, proteolysis, NF-κB nuclear translocation, TNF signaling, IL-1 signaling, Rel family transcription factors, inflammation, transcriptional regulation
- MeSH terms
- NF-KappaB Inhibitor alpha, Amino Acid Sequence, Animals, DNA-Binding Proteins, Humans, Molecular Sequence Data, Phosphorylation, Transcription Factors, Ubiquitins, Signal Transduction, Down-Regulation, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Proteins, I-kappa B Kinase, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review